title: Comparison of generic zidovudine + lamivudine (Cipla, Duovir) and the GlaxoSmithKline brand (Combivir) tablets.
authors.forename: Keith
authors.initials: K
authors.lastname: Henry
authors.forename: Richard
authors.initials: R
authors.lastname: Brundage
authors.forename: Dennis
authors.initials: D
authors.lastname: Weller
authors.forename: Omobosola
authors.initials: O
authors.lastname: Akinsete
authors.forename: Anita
authors.initials: A
authors.lastname: Shet
mesh_terms: D002851:Chromatography, High Pressure Liquid; D003365:Costs and Cost Analysis; D004338:Drug Combinations; D016568:Drugs, Generic / Q000032:analysis* / Q000191:economics / Q000592:standards; D015658:HIV Infections / Q000188:drug therapy / Q000191:economics; D006801:Humans; D019259:Lamivudine / Q000032:analysis* / Q000191:economics / Q000592:standards; D013607:Tablets / Q000032:analysis* / Q000592:standards; D015215:Zidovudine / Q000032:analysis* / Q000191:economics / Q000592:standards
chemical_list: D004338:Drug Combinations; D016568:Drugs, Generic; D013607:Tablets; C109078:lamivudine, zidovudine drug combination; D019259:Lamivudine; D015215:Zidovudine